Pilot Study Evaluating Efficacy and Economic Advantage of Sucrosomial Iron Post-operative Supplementation vs Standard of Care in Patients After Cardiac Surgery

Principal Investigator: Margit Kaufman, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 06970925
Englewood Health IRB #: E-25-119
More Information (clinicaltrials.gov)
 

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women (ROMA:Women)

Principal Investigator: Molly Schultheis, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 04124120
Englewood Health IRB #: E-23-928
More Information (clinicaltrials.gov)

Evaluation of the Navitor Transcatheter Heart Valve in Low and Intermediate Risk Patients who have Severe, Symptomatic, Aortic Stenosis Requiring Aortic Valve Replacement

Principal Investigator: Ramin Hastings, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 05932615
Englewood Health IRB #: E-25-152
More Information (clinicaltrials.gov)

Medtronic Global SYMPLICITY Registery (GSR) Denervation Findings in Real World (DEFINE) – US Cohort

Principal Investigator: Joseph De Gregorio, MD
Coordinator: Dana Connel
Phone: 201-894-3928
NCT #: 01534299
Englewood Health IRB #: E-25-158
More Information (clinicaltrials.gov)

REvascularization CHoices Among under-Represented Groups Evaluation: The RECHARGE Trial

Principal Investigator: Molly Schultheis, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 06399705
Englewood Health IRB #: E-24-970
More Information (clinicaltrials.gov)

REvascularization CHoices Among under-Represented Groups Evaluation: The RECHARGE Trial, Women

Principal Investigator: Molly Schultheis, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 06399692
Englewood Health IRB #: E-24-970
More Information (clinicaltrials.gov)

Safety and Efficacy of the Alleviant No-Implant Intreatrial Shunt in Patients with Heart Failure and Reduced Ejection Fraction

Principal Investigator: Ramin Hastings, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 06812533
Englewood Health IRB #: E-26-177
More Information (clinicaltrials.gov)

SELUTION4DeNovo Small Vessel: A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR014 PTCA Drug Eluting Balloon in the Treatment of Subjects with De Novo Coronary Lesions in Small Vessels

Principal Investigator: Joseph De Gregorio, MD
Coordinator: Dana Connel
Phone: 201-894-3928
NCT #: 05946629
Englewood Health IRB #: E-24-994
More Information (clinicaltrials.gov)

The One-Month Dual Anti-Platelet Therapy with Ticagrelor In CABG Patients Trial (ODIN Trial)

Principal Investigator: Molly Schultheis, MD
Coordinator: Jennifer Snyder
Phone: 201-608-2512
NCT #: 05997693
Englewood Health IRB #: E-24-985
More Information (clinicaltrials.gov)
 

Low Coverage Whole-Genome Circulating Tumor DNA Profiling to Identify Early Mortality Risk in Advanced Non-Small Cell Lung Cancer

Principal Investigator: Christos Stavropoulos, MD
Coordinator: Kayla Williams
Phone: 201-894-9786
NCT #: N/A
Englewood Health IRB #: E-26-182
 

Gestational Diabetes and Metabolic Risk Reduction in a Community-based Wellness Program

Principal Investigator: Anita Ramsetty, MD
Coordinator: Dana Connel
Phone: 201-894-3928
NCT #: Pending
Englewood Health IRB #: E-25-116
 

Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent or Refractory Clostridium Difficile Infection (CDI)

Principal Investigator: Marc Fiorillo, MD
Coordinator: Dara Herman
Phone: 201-894-3944
NCT #: 01942447
Englewood Health IRB #: E-13-507
More Information (clinicaltrials.gov)
 

Studying Chemotherapy with or without Panitumumab for Advanced Pancreatic Caner Without KRAS Mutations

Principal Investigator: Meng Wu, MD
Coordinator: Kayla Williams
Phone: 201-894-9786
NCT #: 06998940
Englewood Health IRB #: E-26-185
More Information (clinicaltrials.gov)

Testing the addition of total ablative therapy to usual systemic therapy treatment for limited metastatic colorectal cancer

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 05673148
Englewood Health IRB #: E-26-189
More Information (clinicaltrials.gov)
 

An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects with Solid Tumors or Lymphoma

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Kayla Williams
Phone: 201-894-9786
NCT #: 03556228
Englewood Health IRB #: E-24-977
More Information (clinicaltrials.gov)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial

Principal Investigator: Allison Imahiyerobo, APN
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 5896189
Englewood Health IRB #: E-25-136
More Information (clinicaltrials.gov)

Collecting Blood Samples from Patients with and without Cancer to Evaluate Tests for Early Cancer Detection

Principal Investigator: Cherif Boutros, MD
Coordinator: Kayla Williams
Phone: 201-894-9786
NCT #: 05334069
Englewood Health IRB #: E-26-181
More Information (clinicaltrials.gov)

Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics

Principal Investigator: Allison Imahiyerobo, APN
Coordinator: Kayla Williams
Phone: 201-894-9786
NCT #: 06418204
Englewood Health IRB #: E-25-135
More Information (clinicaltrials.gov)

NRG-BN003: A Phase III Trial of Observation vs. Irradiation for a Gross Totally Resected Grade II Meningioma

Principal Investigator: Malay Rao, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 03180268
Englewood Health IRB #: E-26-170
More Information (clinicaltrials.gov)

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnofe Irreversible Electroporation (IRE) System

Principal Investigator: Cherif Boutros, MD
Coordinator: Kayla Williams
Phone: 201-894-9786
NCT #: 06937996
Englewood Health IRB #: E-24-987
More Information (clinicaltrials.gov)

Phase III Randomized Trial of Standard Systemic Therapy (SST) versus Standard Systemic Therapy plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer

Principal Investigator: Brian Kim, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 03678025
Englewood Health IRB #: E-24-102
More Information (clinicaltrials.gov)

Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Principal Investigator: Cherif Boutros, MD
Coordinator: Kayla Williams
Phone: 201-894-9786
NCT #: 06681818
Englewood Health IRB #: E-24-982
More Information (clinicaltrials.gov)

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 05929768
Englewood Health IRB #: E-24-101
More Information (clinicaltrials.gov)

Testing the addition of bevacizumab to Osimertinib (AZD9291) as a first-treatment for patients with EGFR-mutant lung cancer that has metastasized

Principal Investigator: Lewis Attas, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04181060
Englewood Health IRB #: E-24-968
More Information (clinicaltrials.gov)

Testing the use of Combination Therapy in Adult Patients with Newly Diagnosed Multiple Myeloma

Principal Investigator: Maxwell Janosky, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04566328
Englewood Health IRB #: E-25-139
More Information (clinicaltrials.gov)
 

A012303, ShortStop-HER2: Shortened duration of adjuvant therapy in patients with early-stage HER2+ breast cancer who achieve pCR after neoadjuvant chemotherapy with HER2 blockade

Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 0876714
Englewood Health IRB #: E-25-165
More Information (clinicaltrials.gov)

DCIS: RECAST Trial - Dcutal Carcinomain Situ: Re-evaluating Conditions for Active Surveillance Suitability as Treatment: a breast cancer prevention pilot study

Principal Investigator: Jennifer Marti, MD
Coordinator: Kayla Williams
Phone: 201-894-9786
NCT #: 06075953
Englewood Health IRB #: E-25-126
More Information (clinicaltrials.gov)
 

A021703: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04094688
Englewood Health IRB #: E-19-792
More Information (clinicaltrials.gov)
 

Testing the addition of high dose, targeted radiation to the usual treatment for locally advanced inoperable non-small cell lung cancer

Principal Investigator: Malay Rao, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 05624996
Englewood Health IRB #: E-26-180
More Information (clinicaltrials.gov)

Testing the addition of radiation therapy to the usual immune therapy treatment (atezolizumba) for patients with extensive stage small cell lung cancer

Principal Investigator: Malay Rao, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04402788
Englewood Health IRB #: E-26-171
More Information (clinicaltrials.gov)
 

DEXTERITY-AFP: Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation  After Thrombus Removal to Yield Benefit in Acute  Femoropopliteal DVT

Principal Investigator: Thomas Bernik, MD
Coordinator: Dana Connel
Phone: 201-894-3928
NCT #: 04862468
Englewood Health IRB #: E-24-106
More Information (clinicaltrials.gov)

Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Iliofemoral Venous Obstruction

Principal Investigator: Steven Elias, MD
Coordinator: Dana Connel
Phone: 201-894-3928
NCT #: 05489588
Englewood Health IRB #: E-22-912
More Information (clinicaltrials.gov)

TANGO-3: Temsirolimus Adventitial Delivery to Improve Angioplasty and/or Atherectomy Revascularization Outcomes Below the Knee (Phase 3)

Principal Investigator: Thomas Bernik, MD
Coordinator: Dana Connel
Phone: 201-894-3928
NCT #: 04433572
Englewood Health IRB #: E-24-107
More Information (clinicaltrials.gov)